These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12829033)

  • 1. Therapeutic drug monitoring in the treatment of HIV-infection.
    Gerber JG; Acosta EP
    J Clin Virol; 2003 Jul; 27(2):117-28. PubMed ID: 12829033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring in HIV infection: current status and future directions.
    Back D; Gatti G; Fletcher C; Garaffo R; Haubrich R; Hoetelmans R; Kurowski M; Luber A; Merry C; Perno CF
    AIDS; 2002 Mar; 16 Suppl 1():S5-37. PubMed ID: 12035820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical benefit of interventions driven by therapeutic drug monitoring.
    Rendón A; Núñez M; Jiménez-Nácher I; González de Requena D; González-Lahoz J; Soriano V
    HIV Med; 2005 Sep; 6(5):360-5. PubMed ID: 16156885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic drug monitoring of antiretrovirals for people with HIV.
    Kredo T; Van der Walt JS; Siegfried N; Cohen K
    Cochrane Database Syst Rev; 2009 Jul; (3):CD007268. PubMed ID: 19588422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV/AIDS management in office practice. Antiretroviral therapy.
    Hartman AF
    Prim Care; 1997 Sep; 24(3):531-60. PubMed ID: 9271691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The advantages of therapeutic drug monitoring in patients receiving antiretroviral treatment and experiencing medication-related problems.
    Schoenenberger JA; Aragones AM; Cano SM; Puig T; Castello A; Gomez-Arbones X; Porcel JM
    Ther Drug Monit; 2013 Feb; 35(1):71-7. PubMed ID: 23188184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease inhibitor plasma concentrations in HIV antiretroviral therapy.
    Justesen US
    Dan Med Bull; 2008 Nov; 55(4):165-85. PubMed ID: 19232158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving HIV infection management using antiretroviral plasma drug levels monitoring: a clinician's point of view.
    Clevenbergh P; Mouly S; Sellier P; Badsi E; Cervoni J; Vincent V; Trout H; Bergmann JF
    Curr HIV Res; 2004 Oct; 2(4):309-21. PubMed ID: 15544452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical pharmacology of antiretroviral therapy.
    Di Perri G; Sinicco A; Audagnotto S; Gobbi F; Canta F; Marrone R; Bonora S
    New Microbiol; 2004 Apr; 27(2 Suppl 1):131-4. PubMed ID: 15646076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?
    Aarnoutse RE; Schapiro JM; Boucher CA; Hekster YA; Burger DM
    Drugs; 2003; 63(8):741-53. PubMed ID: 12662123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical issues in therapeutic drug monitoring of antiretroviral drugs.
    Van Heeswijk RP
    Ther Drug Monit; 2002 Jun; 24(3):323-31. PubMed ID: 12021621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits and Limits of Antiretroviral Drug Monitoring in Routine Practice.
    Maitre T; Muret P; Blot M; Waldner A; Duong M; Si-Mohammed A; Chavanet P; Aho S; Piroth L
    Curr HIV Res; 2019; 17(3):190-197. PubMed ID: 31490758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic drug monitoring of antiretroviral drugs in HIV-infected patients.
    Punyawudho B; Singkham N; Thammajaruk N; Dalodom T; Kerr SJ; Burger DM; Ruxrungtham K
    Expert Rev Clin Pharmacol; 2016 Dec; 9(12):1583-1595. PubMed ID: 27626677
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Position paper on therapeutic drug monitoring of antiretroviral agents.
    Acosta EP; Gerber JG;
    AIDS Res Hum Retroviruses; 2002 Aug; 18(12):825-34. PubMed ID: 12201904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?
    Ribera E; López-Cortés LF; Soriano V; Casado JL; Mallolas J
    Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():41-67. PubMed ID: 16373004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic drug monitoring and drug-drug interactions involving antiretroviral drugs.
    Boffito M; Acosta E; Burger D; Fletcher CV; Flexner C; Garaffo R; Gatti G; Kurowski M; Perno CF; Peytavin G; Regazzi M; Back D
    Antivir Ther; 2005; 10(4):469-77. PubMed ID: 16038472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic drug monitoring in HIV treatment: a literature review.
    Wertheimer BZ; Freedberg KA; Walensky RP; Yazdanapah Y; Losina E
    HIV Clin Trials; 2006; 7(2):59-69. PubMed ID: 16798621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral resistance: a major challenge in managing HIV disease.
    Boucher CA; Reedijk M
    J Biol Regul Homeost Agents; 1995; 9(3):91-4. PubMed ID: 8782014
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of therapeutic drug monitoring in pediatric HIV/AIDS.
    Burger DM
    Ther Drug Monit; 2010 Jun; 32(3):269-72. PubMed ID: 20445482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, antiretroviral therapy, and emergence of resistance to antiretroviral agents in HIV-2 infection: a review.
    Hightower M; Kallas EG
    Braz J Infect Dis; 2003 Feb; 7(1):7-15. PubMed ID: 12807687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.